ewaldux
Bullish
now
@GBOGHB Actually, Because someone wants to steal your cheap shares. Oficially, $SAVA company reported top-line results from a Phase 2b study of PTI-125, its lead investigational drug, in patients with Alzheimer's disease, didn't meet its primary endpoint. BUT COMPANY IS NOT GOING TO BK! Just wait for the next PR.
  • 2
2 Likes